Report overview
Serum biomarkers are proteins generally detected in urine, blood, and Others bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.
This report aims to provide a comprehensive presentation of the global market for Serum Cancer Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum Cancer Biomarkers. This report contains market size and forecasts of Serum Cancer Biomarkers in global, including the following market information:
Global Serum Cancer Biomarkers Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Serum Cancer Biomarkers Market Sales, 2018-2023, 2024-2030, (MT)
Global top five Serum Cancer Biomarkers companies in 2022 (%)
The global Serum Cancer Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global serum cancer biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be anOthers key driver of the market.
We surveyed the Serum Cancer Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Serum Cancer Biomarkers Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Serum Cancer Biomarkers Market Segment Percentages, by Type, 2022 (%)
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others
Global Serum Cancer Biomarkers Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Serum Cancer Biomarkers Market Segment Percentages, by Application, 2022 (%)
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
Global Serum Cancer Biomarkers Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Serum Cancer Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Serum Cancer Biomarkers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Serum Cancer Biomarkers revenues share in global market, 2022 (%)
Key companies Serum Cancer Biomarkers sales in global market, 2018-2023 (Estimated), (MT)
Key companies Serum Cancer Biomarkers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead
Outline of Major Chapters:
Chapter 1: Introduces the definition of Serum Cancer Biomarkers, market overview.
Chapter 2: Global Serum Cancer Biomarkers market size in revenue and volume.
Chapter 3: Detailed analysis of Serum Cancer Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Serum Cancer Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Serum Cancer Biomarkers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
